SCHEMBL3380790

SCHEMBL3380790

CC(=O)c1c(N)cccc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.57
CDC25B P30305 1/20 0.47
G6PD P11413 1/20 0.47
CASP7 P55210 1/20 0.47
CASP6 P55212 1/20 0.47
HSD17B10 Q99714 4/20 0.45
KDM4E B2RXH2 3/20 0.45
NPC1 O15118 1/20 0.45
CASP3 P42574 1/20 0.45
RAB9A P51151 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
ALDH1A1 P00352 4/20 0.44
ALOX15 P16050 1/20 0.44
THRB P10828 1/20 0.43
MYC P01106 1/20 0.43
HPGD P15428 2/20 0.42
MAPT P10636 2/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL29094370 0.88 MMP2 (0.57) MMP2CDC25BG6PDCASP7CASP6
SCHEMBL3502815 0.88 THRB (0.46) MMP2CDC25BG6PDCASP7CASP6
SCHEMBL48723 0.85 MMP2 (0.63) MMP2CDC25BG6PDCASP7CASP6
SCHEMBL15869337 0.85 MMP2 (0.63) MMP2CDC25BG6PDCASP7CASP6
SCHEMBL27925721 0.85 MMP2 (0.63) MMP2CDC25BG6PDCASP7CASP6
SCHEMBL29367294 0.85 MMP2 (0.63) MMP2CDC25BG6PDCASP7CASP6
SCHEMBL15049648 0.85 ALDH1A1 (0.55) MMP2G6PDCASP7CASP6HSD17B10
SCHEMBL31024653 0.84 MMP2 (0.52) MMP2CDC25BG6PDCASP7CASP6
SCHEMBL7833293 0.84 MMP2 (0.52) MMP2CDC25BG6PDCASP7CASP6
SCHEMBL8070939 0.83 MMP2 (0.61) MMP2CDC25BG6PDCASP7CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010062959-A1 5-HT4 RECEPTOR AGONISTS FOR TREATING IRRITABLE BOWEL SYNDROME AND COLONIC HYPERSENSITIVITY ARYX THERAPEUTICS, INC. (US) 2010-06-03 WO claimed
EP-2707224-B1 POLYMER COMPOSITIONS AND METHODS SAUDI ARAMCO TECH CO (SA) 2017-10-25 EP disclosed
CN-105658229-A Compounds, compositions and methods for the treatment of diseases through inhibiting TGF-beta activity 南方研究所 2016-06-08 CN disclosed
CN-103889963-B The similar thing of quinazolinone and the similar thing of quinazolinone are being used for the treatment of or are preventing the application in some virus infection SOUTHERN RESEARCH INSTITUTE (US) 2016-01-20 CN disclosed
CN-102822192-B Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen ST GEORGE'S HOSPITAL MEDICAL SCHOOL (GB) 2015-09-30 CN disclosed
CN-103694161-B The manufacture method of pharmaceutically active agents H. LUNDHECK A/S (DK) 2015-09-09 CN disclosed
CN-104471058-A Compositions comprising chalcogenides and related methods HUTCHINSON FRED CANCER RES 2015-03-25 CN disclosed
CN-102269932-B Radiation-sensitive resin composition, cured film and forming method thereof and display element JSR CORP 2015-03-25 CN disclosed
CN-104395317-A Heterocycle-fused morphinans, use thereof and preparation thereof SOUTHERN RES INST 2015-03-04 CN disclosed
CN-102656146-B Process for the manufacture of pharmaceutically active agents LUNDBECK & CO AS H 2014-12-17 CN disclosed
CN-1237598-A Hollow sphere organic pigment for paper or paper coating ROHM & HAAS (US) 1999-12-08 CN disclosed
CN-1230957-A Process for synthesis of benzothiophenes LILLY CO ELI (US) 1999-10-06 CN disclosed
CN-1180353-A Process for preparing 2-substituted benzo [ b ] thiophenes and intermediates thereof LILLY CO ELI (US) 1998-04-29 CN disclosed
CN-1157822-A Pharmaceutical compounds LILLY INDUSTRIES LTD (GB) 1997-08-27 CN disclosed
CN-1137525-A Naphthyl compounds, intermediates, compositions and methods LILLY CO ELI (US) 1996-12-11 CN disclosed
CN-1130634-A Encapsulated hydrophilic polymers and their preparation ROHM & HAAS (US) 1996-09-11 CN disclosed
CN-1109884-A Methods of inhibiting myeloperoxidase activity LILLY CO ELI (US) 1995-10-11 CN disclosed
CN-1108255-A Methods of inhibiting the symtoms of premenstrual syndrome/late luteal phase dysphoric disorder LILLY CO ELI (US) 1995-09-13 CN disclosed
CN-1107157-A Methods for the treatment of peri-menopausal syndrome LILLY CO ELI (US) 1995-08-23 CN disclosed
CN-1105359-A Methods for inhibiting smooth muscle cell proliferation and restinosis LILLY CO ELI (US) 1995-07-19 CN disclosed